CD4 and neoplasm: Interestingly, the combination of IL12-MSA and IL2-MSA led to an increased fraction of CD4+ T cells that were Tregs in the TdLN and spleen but a significantly decreased Treg fraction in tumor-bearing lungs (Figure 4A).